DHB — Delivra Health Brands Cashflow Statement
0.000.00%
- CA$5.63m
- CA$3.93m
- CA$12.38m
- 62
- 84
- 39
- 65
Annual cashflow statement for Delivra Health Brands, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -81.4 | -28.5 | -7.01 | -0.184 | 0.876 |
Depreciation | |||||
Non-Cash Items | 63.8 | 18.5 | 1.76 | -0.858 | -1.23 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -3.87 | -2.25 | -1.31 | -1.38 | -0.198 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Cash from Operating Activities | -18.4 | -9.65 | -4.44 | -1.09 | 0.756 |
Capital Expenditures | -6.32 | -0.033 | -0.022 | -0.041 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 2.68 | 12.3 | 1.37 | 2.95 | 0.011 |
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Sale of Intangible Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -3.64 | 12.3 | 1.35 | 2.91 | 0.011 |
Financing Cash Flow Items | 0 | 4.49 | 0 | — | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 3.17 | 0.446 | -0.309 | -0.255 | 0.594 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -18.9 | 3.02 | -3.35 | 1.64 | 1.48 |